RU2522582C2 - Новые противомикробные средства - Google Patents
Новые противомикробные средства Download PDFInfo
- Publication number
- RU2522582C2 RU2522582C2 RU2011124795/04A RU2011124795A RU2522582C2 RU 2522582 C2 RU2522582 C2 RU 2522582C2 RU 2011124795/04 A RU2011124795/04 A RU 2011124795/04A RU 2011124795 A RU2011124795 A RU 2011124795A RU 2522582 C2 RU2522582 C2 RU 2522582C2
- Authority
- RU
- Russia
- Prior art keywords
- heteroaryl
- formula
- compounds
- alkyl
- compound
- Prior art date
Links
- LIWIOZYPTDFUMX-RDJZCZTQSA-N C[C@@H](C(N(CC1)CCN1c(c(F)cc(N(C[C@H](C[n]1nncc1)O1)C1=O)c1)c1F)=O)NC(c1cnccn1)=O Chemical compound C[C@@H](C(N(CC1)CCN1c(c(F)cc(N(C[C@H](C[n]1nncc1)O1)C1=O)c1)c1F)=O)NC(c1cnccn1)=O LIWIOZYPTDFUMX-RDJZCZTQSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2623/DEL/2008 | 2008-11-20 | ||
| IN2623DE2008 | 2008-11-20 | ||
| PCT/IN2009/000658 WO2010058423A2 (en) | 2008-11-20 | 2009-11-18 | Novel antimicrobials |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2011124795A RU2011124795A (ru) | 2012-12-27 |
| RU2522582C2 true RU2522582C2 (ru) | 2014-07-20 |
Family
ID=42198604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011124795/04A RU2522582C2 (ru) | 2008-11-20 | 2009-11-18 | Новые противомикробные средства |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8841306B2 (enExample) |
| EP (1) | EP2367820B1 (enExample) |
| JP (1) | JP5662940B2 (enExample) |
| KR (1) | KR20110092309A (enExample) |
| CN (1) | CN102224151A (enExample) |
| AR (1) | AR074387A1 (enExample) |
| AU (1) | AU2009318783A1 (enExample) |
| CA (1) | CA2743971A1 (enExample) |
| MX (1) | MX2011005365A (enExample) |
| RU (1) | RU2522582C2 (enExample) |
| WO (1) | WO2010058423A2 (enExample) |
| ZA (1) | ZA201103978B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2627653B1 (en) | 2010-10-13 | 2014-12-24 | Glaxo Group Limited | 3-amino-pyrazole derivatives useful against tuberculosis |
| PT106651A (pt) * | 2012-11-20 | 2014-05-20 | Tecnimede Sociedade Tecnico Medicinal S A | Quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadas |
| CN103450173B (zh) * | 2013-09-07 | 2015-06-03 | 吉首大学 | 吡咯酮-苯基-噁唑烷酮型化合物及其制法和用途 |
| US10995097B2 (en) * | 2016-03-11 | 2021-05-04 | The Board Of Trustees Of The University Of Illinois | Small molecules active against gram-negative bacteria |
| US11274106B2 (en) | 2017-06-23 | 2022-03-15 | The Board Of Trustees Of The University Of Illinois | Topoisomerase inhibitors with antibacterial and anticancer activity |
| EP4100023A4 (en) * | 2020-02-07 | 2024-03-13 | University of South Florida | Inhibition of beta-arrestin oligomerization in tauopathy |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA007490B1 (ru) * | 2002-02-25 | 2006-10-27 | Фармация Энд Апджон Компани | N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2119556C (en) | 1991-11-01 | 2004-07-06 | Michael Robert Barbachyn | Substituted aryl- and heteroaryl-phenyloxazolidinones |
| SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| US5646244A (en) | 1993-09-06 | 1997-07-08 | Fujisawa Pharmaceutical Co., Ltd. | Cyclodepsipeptide compound |
| FI974180A0 (fi) | 1995-05-11 | 1997-11-10 | Upjohn Co | Spirosyklisiä ja bisyklisiä diatsinyyli- ja karbatsinyylioksatsolidinoneja |
| CA2228647A1 (en) | 1995-09-01 | 1997-03-13 | Pharmacia & Upjohn Company | Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
| GB9702213D0 (en) * | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| SK18362000A3 (sk) | 1998-06-05 | 2001-06-11 | Astrazeneca Ab | Oxazolidinónové deriváty, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú |
| JP2000204084A (ja) | 1998-11-11 | 2000-07-25 | Hokuriku Seiyaku Co Ltd | チオカルバミド酸誘導体 |
| WO2000029396A1 (de) | 1998-11-17 | 2000-05-25 | Bayer Aktiengesellschaft | Neue substituierte phenyloxazolidon-derivate |
| BR0010982A (pt) | 1999-05-27 | 2002-03-05 | Upjohn Co | Novas oxazolidinonas bicìclicas como agentes antibacterianos |
| US6608081B2 (en) | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| US6689779B2 (en) | 2000-06-05 | 2004-02-10 | Dong A Pharm. Co., Ltd. | Oxazolidinone derivatives and a process for the preparation thereof |
| ES2245698T3 (es) | 2000-06-30 | 2006-01-16 | PHARMACIA & UPJOHN COMPANY LLC | Composiciones para el tratamiento de infecciones bacterianas que contienen un compuesto de oxazolidinona, sulbactam y ampicilina. |
| WO2003008389A1 (en) | 2001-07-16 | 2003-01-30 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as potential antimicrobials |
| DOP2002000333A (es) | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz |
| GB0108793D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
| WO2002081470A1 (en) | 2001-04-07 | 2002-10-17 | Astrazeneca Ab | Oxazolidinones containing a sulfonimid group as antibiotics |
| JP2004534097A (ja) | 2001-07-09 | 2004-11-11 | フアルマシア・イタリア・エツセ・ピー・アー | ＴＣＦ−４とβ−カテニンの相互作用阻害剤 |
| KR20040106551A (ko) | 2002-05-15 | 2004-12-17 | 랜박시 래보러터리스 리미티드 | 페닐 옥사졸리디논 유도체의 다형 제제 |
| WO2003097640A1 (en) | 2002-05-22 | 2003-11-27 | Orchid Chemicals & Pharmaceuticals Ltd. | Oxazolidinone derivatives as antibacterial agents |
| WO2004009587A1 (en) | 2002-07-22 | 2004-01-29 | Orchid Chemicals & Pharmaceuticals Ltd | Oxazolidinone derivatives as antibacterial agents |
| AU2002319848A1 (en) | 2002-07-29 | 2004-02-25 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| AU2003253141A1 (en) * | 2002-08-22 | 2004-03-11 | Orchid Chemicals And Pharmaceuticals Ltd | Novel antibacterial agents |
| US6875784B2 (en) | 2002-10-09 | 2005-04-05 | Pharmacia & Upjohn Company | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives |
| AR042086A1 (es) * | 2002-11-21 | 2005-06-08 | Upjohn Co | N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos |
| GB0229526D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| GB0229518D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| CN1237056C (zh) * | 2002-12-25 | 2006-01-18 | 中国科学院上海药物研究所 | 噁唑烷酮类化合物、其制备方法和用途 |
| WO2004089944A1 (en) * | 2003-04-07 | 2004-10-21 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| BRPI0409217A (pt) | 2003-04-09 | 2006-03-28 | Pharmacia & Upjohn Co Llc | derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona |
| WO2004113329A1 (en) | 2003-06-20 | 2004-12-29 | Orchid Chemicals And Pharmaceuticals Ltd. | Oxazole derivatives as antibacterial agents |
| WO2005003087A2 (en) | 2003-07-01 | 2005-01-13 | Orchid Chemicals And Pharmaceuticals Ltd. | Oxazole derivatives as antibacterial agents |
| JP2007521284A (ja) | 2003-07-02 | 2007-08-02 | メルク アンド カンパニー インコーポレーテッド | オキサゾリジノン系抗生物質及びその誘導体 |
| CA2529292A1 (en) | 2003-07-02 | 2005-01-20 | Merck & Co., Inc. | Oxazolidinone antibiotics and derivatives thereof |
| US20050118624A1 (en) * | 2003-10-03 | 2005-06-02 | Cumbre Inc. | Fluorescent probes for ribosomes and method of use |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| WO2005082897A1 (en) | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone antibacterial agents |
| WO2005082900A2 (en) | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone amidoximes as antibacterial agents |
| US20080064689A1 (en) | 2004-05-25 | 2008-03-13 | Astrazeneca Ab | 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents |
| JP2008500319A (ja) | 2004-05-25 | 2008-01-10 | アストラゼネカ アクチボラグ | 細菌感染症の治療のためのｍａｏ阻害剤としての３−（４−（２−ジヒドロイソオキサゾール−３−イルピリジン−５−イル）フェニル−５−トリアゾール−１−イルメチルオキサゾリジン−２−オン誘導体 |
| WO2006035283A1 (en) | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| WO2006043121A1 (en) | 2004-10-20 | 2006-04-27 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| US8067418B2 (en) | 2005-04-12 | 2011-11-29 | Vicore Pharma Ab | Tricyclic angiotensin II agonists |
| EP1745784A1 (en) | 2005-06-27 | 2007-01-24 | Ferrer Internacional, S.A. | Oxazolidinone derivatives and use thereof as antibiotics |
| CA2614105A1 (en) | 2005-07-06 | 2007-01-11 | Pharmacia & Upjohn Company Llc | Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
| KR20070038236A (ko) | 2005-10-05 | 2007-04-10 | 일동제약주식회사 | 신규 옥사졸리디논 포름 아미드 유도체 및 그 제조방법 |
| CA2637052A1 (en) * | 2006-01-19 | 2007-07-26 | Laboratorios Salvat, S.A. | Dicarbonylic compounds with antibacterial activity |
| ES2331930T3 (es) | 2006-02-14 | 2010-01-20 | Pfizer Products Inc. | Oxazolidinonas con benzoxazinonas y benzoxazepinonas como agentes antibacterianos. |
| CN100406455C (zh) | 2006-02-20 | 2008-07-30 | 中国科学院上海药物研究所 | 含三氮唑基的噁唑烷酮类化合物及其制备方法和用途 |
| US8148362B2 (en) | 2006-03-31 | 2012-04-03 | Research Foundation Itsuu Laboratory | Compound having heterocyclic ring |
| WO2009001192A2 (en) * | 2007-06-22 | 2008-12-31 | Orchid Research Laboratories Limited | Novel compounds and their use |
| CN101434584A (zh) * | 2007-11-15 | 2009-05-20 | 中山大学 | 具有抗菌活性的手性噁唑烷酮类化合物 |
-
2009
- 2009-11-18 RU RU2011124795/04A patent/RU2522582C2/ru not_active IP Right Cessation
- 2009-11-18 CN CN2009801465662A patent/CN102224151A/zh active Pending
- 2009-11-18 MX MX2011005365A patent/MX2011005365A/es not_active Application Discontinuation
- 2009-11-18 CA CA2743971A patent/CA2743971A1/en not_active Abandoned
- 2009-11-18 KR KR1020117013609A patent/KR20110092309A/ko not_active Ceased
- 2009-11-18 AU AU2009318783A patent/AU2009318783A1/en not_active Abandoned
- 2009-11-18 US US13/130,440 patent/US8841306B2/en not_active Expired - Fee Related
- 2009-11-18 EP EP09827270.1A patent/EP2367820B1/en not_active Not-in-force
- 2009-11-18 JP JP2011537013A patent/JP5662940B2/ja not_active Expired - Fee Related
- 2009-11-18 WO PCT/IN2009/000658 patent/WO2010058423A2/en not_active Ceased
- 2009-11-20 AR ARP090104485A patent/AR074387A1/es not_active Application Discontinuation
-
2011
- 2011-05-30 ZA ZA2011/03978A patent/ZA201103978B/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA007490B1 (ru) * | 2002-02-25 | 2006-10-27 | Фармация Энд Апджон Компани | N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5662940B2 (ja) | 2015-02-04 |
| CA2743971A1 (en) | 2010-05-27 |
| US8841306B2 (en) | 2014-09-23 |
| MX2011005365A (es) | 2011-06-24 |
| ZA201103978B (en) | 2012-09-26 |
| CN102224151A (zh) | 2011-10-19 |
| WO2010058423A3 (en) | 2010-12-09 |
| EP2367820B1 (en) | 2016-09-21 |
| WO2010058423A9 (en) | 2011-04-28 |
| EP2367820A2 (en) | 2011-09-28 |
| AR074387A1 (es) | 2011-01-12 |
| EP2367820A4 (en) | 2012-06-20 |
| JP2012509313A (ja) | 2012-04-19 |
| KR20110092309A (ko) | 2011-08-17 |
| WO2010058423A2 (en) | 2010-05-27 |
| RU2011124795A (ru) | 2012-12-27 |
| US20110245258A1 (en) | 2011-10-06 |
| AU2009318783A1 (en) | 2011-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1046276C (zh) | 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途 | |
| US6689779B2 (en) | Oxazolidinone derivatives and a process for the preparation thereof | |
| RU2414469C2 (ru) | Новые производные оксазолидинона | |
| DE602004004808T2 (de) | Acyloxymethylcarbamatoxazolidinone und ihre Präparationen | |
| US20020103186A1 (en) | Oxazolidinone derivatives as antimicrobials disease | |
| HUT75035A (en) | 6-member nitrogen-containing heteroaryl-oxazolidinones, pharmaceutical compositions containing them and process for their preparation | |
| RU2522582C2 (ru) | Новые противомикробные средства | |
| SK6997A3 (en) | Cyclopentanopyridyl-oxazolidinones, which contain a heteroatom, process for producing them, their use and pharmaceutical composition containing such substances | |
| EP1246810B1 (en) | Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials | |
| KR20020067557A (ko) | 설폭시민 관능기를 가지는 옥사졸리디논 및항미생물제로서의 그의 용도 | |
| WO2008143649A2 (en) | Novel oxazolidinone compounds as antiinfective agents | |
| US20040254162A1 (en) | Oxazolidinone derivatives as antimicrobials | |
| EP2766373B1 (en) | Sila analogs of oxazolidinone derivatives and synthesis thereof | |
| KR101653570B1 (ko) | 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 | |
| EP1904489B1 (en) | Process for the synthesis of triazoles | |
| CN113214288A (zh) | 苯并[1,3]噁嗪-噁唑烷酮类化合物及其制备方法和用途 | |
| EP1625124A1 (en) | Oxazolidinone derivatives as antimicrobials | |
| JP2000229978A (ja) | オキサゾリジノン及び抗菌剤としてのそれらの使用 | |
| KR100980681B1 (ko) | 디플루오로페닐 유도체를 갖는 신규한 옥사졸리디논 유도체또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 하는 항생제 조성물 | |
| KR100948345B1 (ko) | 신규한 옥사졸리디논 유도체, 이의 제조방법 및 이를함유하는 의약 조성물 | |
| WO2008090570A1 (en) | Novel antimicrobials | |
| WO2009116090A2 (en) | Novel antimicrobials | |
| KR100674096B1 (ko) | 피리미딘 고리를 포함하는 신규 옥사졸리디논 유도체와그의 제조방법 | |
| KR100629327B1 (ko) | 신규 트리아졸릴메틸옥사졸리디논 유도체 | |
| WO2007004032A1 (en) | Oxazolidiones containing cyclobutane as antibacterial agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20201119 |